| Dr Jeffrey L Burchard, MD | |
|
1105 Central Expy N, Ste 110, Allen, TX 75013-6103 | |
| (972) 727-9877 | |
| (972) 727-5015 |
| Full Name | Dr Jeffrey L Burchard |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 1105 Central Expy N, Allen, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073571394 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | K0429 (Texas) | Primary |
| Entity Name | Family Healthcare Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831159466 PECOS PAC ID: 5496732307 Enrollment ID: O20040701000298 |
News Archive
A team of researchers from McGill University has advanced the scientific understanding of abnormal mineral accumulation in arteries, a complication often seen in patients with chronic kidney disease and diabetes. Mineralized arteries may affect heart functions, leading to death in some instances.
Solta Medical, Inc. (Nasdaq: SLTM) is proud to celebrate the launch of the new Thermage CPT and Fraxel re:store Dual systems with the kick off of the illumiNATION tour (www.illumiNATIONtour.com). Starting September 14 and continuing through November, the illumiNATION tour is bringing the latest breakthroughs in Thermage(R) and Fraxel(R) systems directly to physicians in over 20 cities across the U.S. and 11 cities in Europe.
Lauren Strober, PhD, has been awarded a five-year federal grant for $554,000 to study factors relating to unemployment in people with multiple sclerosis (MS). Dr. Strober is a research scientist at Kessler Foundation, a major center for cognitive research and training in multiple sclerosis and a leader in the field of disability employment.
VIVUS, Inc. today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration is tentatively scheduled to review the Company's New Drug Application for Qnexa® for the treatment of obesity on July 15, 2010.
Following a May 15, 2014, meeting with the U.S. Food and Drug Administration (FDA), Shire plc, the global specialty biopharmaceutical company, announces today that it intends to submit a New Drug Application for lifitegrast as a treatment for the signs and symptoms of dry eye disease in adults in the first-quarter 2015, as we complete remaining chemistry and manufacturing work.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeffrey L Burchard, MD 1105 Central Expy N, Ste 110, Allen, TX 75013-6103 Ph: (972) 727-9877 | Dr Jeffrey L Burchard, MD 1105 Central Expy N, Ste 110, Allen, TX 75013-6103 Ph: (972) 727-9877 |
News Archive
A team of researchers from McGill University has advanced the scientific understanding of abnormal mineral accumulation in arteries, a complication often seen in patients with chronic kidney disease and diabetes. Mineralized arteries may affect heart functions, leading to death in some instances.
Solta Medical, Inc. (Nasdaq: SLTM) is proud to celebrate the launch of the new Thermage CPT and Fraxel re:store Dual systems with the kick off of the illumiNATION tour (www.illumiNATIONtour.com). Starting September 14 and continuing through November, the illumiNATION tour is bringing the latest breakthroughs in Thermage(R) and Fraxel(R) systems directly to physicians in over 20 cities across the U.S. and 11 cities in Europe.
Lauren Strober, PhD, has been awarded a five-year federal grant for $554,000 to study factors relating to unemployment in people with multiple sclerosis (MS). Dr. Strober is a research scientist at Kessler Foundation, a major center for cognitive research and training in multiple sclerosis and a leader in the field of disability employment.
VIVUS, Inc. today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration is tentatively scheduled to review the Company's New Drug Application for Qnexa® for the treatment of obesity on July 15, 2010.
Following a May 15, 2014, meeting with the U.S. Food and Drug Administration (FDA), Shire plc, the global specialty biopharmaceutical company, announces today that it intends to submit a New Drug Application for lifitegrast as a treatment for the signs and symptoms of dry eye disease in adults in the first-quarter 2015, as we complete remaining chemistry and manufacturing work.
› Verified 3 days ago
Dr. Astrid Gutsmann, DO, PH.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 411 E Mcdermott Dr, Allen, TX 75002 Phone: 972-227-3464 Fax: 972-359-9690 | |
Sovannarat Floyd, FNP-BC Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 906 W Mcdermott Dr Ste 124, Allen, TX 75013 Phone: 469-564-1026 | |
Dr. Sadaf Sadruddin Sabzali, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1650 E Stacy Rd Ste 160, Allen, TX 75002 Phone: 214-726-9098 Fax: 972-727-0842 | |
Dr. Nicholas Owon Kpar Atudonyang, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 977 Raintree Cir, Suite 210, Allen, TX 75013 Phone: 214-865-6648 Fax: 214-865-6646 | |
Wallace B Sarver, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1650 E Stacy Rd Ste 160, Allen, TX 75002 Phone: 214-726-9098 Fax: 972-727-0842 | |
Oyindamola Ojuolape Wemimo, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1218 W Mcdermott Dr, Allen, TX 75013 Phone: 972-390-9000 |